Perceived Health After Hospitalization for COVID-19
- Conditions
- COVID-19, Post-hospitalization, Disease Impact
- Interventions
- Other: Questionnaires
- Registration Number
- NCT04912804
- Lead Sponsor
- Centre Hospitalier Universitaire Dijon
- Brief Summary
There are currently no precise data available on the impact of COVID-19 on the daily life of patients after hospitalization. For the moment, studies have only demonstrated a strong impact of the diagnosis on the domains of quality of life explored by the MOS-SF36 questionnaire and the PHQ-9 depression score. Concerning the impact of COVID-19 disease after conventional hospitalization, field reports indicate extremely intense fatigue and a major physical impact lasting several weeks
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 207
- Adult patient
- Patient with a diagnosis of COVID-19 confirmed by PCR and/or CT scan
- Patient hospitalized in a short stay unit (excluding intensive care and rehabilitation) for a COVID-19 infection
- Patient providing oral consent to participate in the study
- Patient able to understand and answer the questionnaires used
- Patient able to answer the questions on an electronic device and to receive requests by email and/or SMS
- Patient who has electronic equipment at home and an Internet subscription allowing him/her to answer the questionnaires online
- Patient under guardianship, curatorship or a measure of judicial safeguard
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description COVID-19 Patient Questionnaires Patient discharged from a conventional short-stay hospitalization unit.
- Primary Outcome Measures
Name Time Method The value of perceived health scores in patients who achieved PASS and MCII Through study completion, an average of 6 months Time to PASS and CID in patients discharged from conventional hospitalization for COVID-19 disease Through study completion, an average of 6 months
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Chu Dijon Bourogne
🇫🇷Dijon, France